Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; June 2023, Vol. 11 Issue: 6 p550-562, 13p
- Subject
- Language
- ISSN
- 22132600; 22132619